Ultrasensitive spectrofluorimetric approach for quantitation of the novel antiparkinsonian drug safinamide in different matrices at nanogram levels: Assessment of greenness and whiteness profiles
-
Published:2024-04
Issue:
Volume:38
Page:101448
-
ISSN:2352-5541
-
Container-title:Sustainable Chemistry and Pharmacy
-
language:en
-
Short-container-title:Sustainable Chemistry and Pharmacy
Author:
Magdy Galal,Radwan Aya Saad,Elmansi Heba,Belal Fathalla,Abd El-Aziz Mai,El-Abassy Omar M
Funder
European Medicines Agency
U.S. Food and Drug Administration
Food and Drug Administration
Subject
Management, Monitoring, Policy and Law,Pharmaceutical Science,Pollution,Environmental Chemistry
Reference39 articles.
1. Development and validation of stability indicating RP-HPLC method for determination of safinamide mesylate, Jordan;Adhao;J. Pharmaceut. Sci.,2020
2. A green sustainable ultrasensitive micelle-sensitized spectrofluorimetric approach for the estimation of tafamidis in different matrices at picogram levels;Alossaimi;Sustain. Chem. Pharm.,2023
3. Diagnosis and treatment of Parkinson disease: a review;Armstrong;JAMA,2020
4. Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs;Charvin;Nat. Rev. Drug Discov.,2018
5. Safinamide: first global approval;Deeks;Drugs,2015